During the quarter ended June 30, 2026, an officer (as defined in Exchange Act Rule 16a-1(f)) of the Company adopted a written plan for the sale of the Company’s common shares intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c) (“Rule 10b5-1 trading arrangements”) as follows:

On May 12, 2026, Kevin Raketich, Executive Vice President, Strategy and Corporate Development, adopted a 10b5-1 trading arrangement that provides for the potential sale of up to 35,000 common shares, as well as up to 7,800 common shares acquired upon exercise of stock options, which trading arrangement is scheduled to start no earlier than September 8, 2026 and terminate no later than March 31, 2027.

On May 18, 2026, Michael S. Williams, Chief Executive Officer, adopted a 10b5-1 trading arrangement that provides for the potential sale of up to 100,000 common shares, which trading arrangement is scheduled to start no earlier than October 1, 2026 and terminate no later than April 1, 2027.

On May 19, 2026, Kristine C. Syrvalin, Executive Vice President, General Counsel and Chief Human Resources Officer, adopted a 10b5-1 trading arrangement that provides for the potential sale of up to 10,000 common shares, as well as up to 9,092 common shares acquired upon exercise of stock options, which trading arrangement is scheduled to start no earlier than September 8, 2026 and terminate no later than March 30, 2027.

Each of the above-named officers is currently and is expected to remain in compliance with his or her share ownership guidelines following the sale of any common shares pursuant to his or her 10b5-1 trading arrangement.